UP Govt Unveils 9.5 Crore Plan With 20 Institutions For Pharma Growth
The Uttar Pradesh government has introduced its first-ever standard operating procedure (SOP) for the pharmaceutical sector, aiming to strengthen drug manufacturing and clinical research. This initiative is designed to position the state as a global pharma hub by streamlining production and clinical trial processes.
As part of the plan, 20 medical institutions across the state have been onboarded to conduct clinical trials. These institutions will follow globally aligned protocols and receive specialised training to ensure adherence to the best practices. A budget of ₹9.5 crore has been allocated to create a robust ecosystem for pharmaceutical innovation and testing.
The strategy also includes hosting conferences with experts, standardising resources for pharmaceutical counselling, and conducting Good Clinical Practices (GCP) training for doctors and researchers in selected colleges. Partnerships with prominent institutions such as THSTI, AKTU, and BIRAC will further enhance the sector’s capabilities.
This landmark move is expected to unlock new opportunities and address challenges faced by the state’s pharma industry.
2026-09-03
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Cracking Europe: When the Chemical Empire Loses Its Heat
-
Chinese Urea Producers Receive a Timely Boost as Second Round of 2026 Export Quotas Nears 2 Million Tons
-
Sekisui Specialty Chemicals Has Announced a Global Price Increase
-
EU May Build Industry-Level Trade Barriers Against Chinese Chemicals
-
EU Low-Value Parcel Rules Could Disrupt Chemical Sample Flows
-
Do You Know the Food Zero Additives?
-
China’s Titanium Dioxide Giant Makes a Move: LB Group Acquires UK Venator Assets
-
Urea Prices Surge as India Faces Critical Shortages: Will China’s Export Quotas Provide Relief?
-
DKSH Expands Partnership with Assessa to Distribute Botanical Ingredients Across China
-
“Soaring Sulfuric Acid, Tightening Ore Supplies”: The High-Stakes Battle Behind the Titanium Dioxide Price Surge
Recommend Reading
-
Europe’s Chemicals Industry Stalls Again as Cefic Cuts 2025 Outlook
-
Wanhua USA Reaches $7.75 Million Settlement in MDI/TDI Antitrust Lawsuit
-
Global Countries Impose Tariffs on Chinese Chemical Products
-
Mitsubishi Chemical Exits 105,000-Tonne Taiwan MMA Business as China Capacity Reshapes Asian Market
-
The “Counter-Wind Ledger” of CHF 11.2 Billion: Sika Barely Grew in 2025—Yet Kept Taking Market Share
-
2025 Crude Oil Market Prices Decline—Can 2026 Bring a Turning Point?
-
Phosphate market prices slightly decline (12.17-12.24)
-
Recent Polyethylene Prices Have Shifted Lower in China
-
Premium Global Chemical Sourcing Requests (20-24 Dec 2025)
-
Supply-side Disruptions Cause Dramatic Fluctuations in Lithium Carbonate Prices